About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Urology
›
top-articles
Department of Urology
372
(top 1%)
papers
15.8K
(top 1%)
citations
56
(top 1%)
h
-index
117
(top 1%)
g
-index
396
all documents
17.0K
doc citations
1.9K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
European Urology
2017
1,594
2
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
European Urology
2019
936
3
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
European Urology
2015
804
4
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
European Urology
2018
627
5
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
European Urology
2009
584
6
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
European Urology
2022
559
7
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
European Urology
2021
532
8
Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence
Journal of Urology
1996
409
9
High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience
Urology
2004
321
10
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responsesin vitro
International Journal of Cancer
2006
276
11
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
World Journal of Urology
2017
260
12
Clinically Relevant Reduction in Risk of Recurrence of Superficial Bladder Cancer Using 5-Aminolevulinic Acid-Induced Fluorescence Diagnosis: 8-Year Results of Prospective Randomized Study
Urology
2007
252
13
Shock Wave Technology and Application: An Update
European Urology
2011
251
14
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
Nature Medicine
2020
245
15
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
European Urology
2016
215
16
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
European Urology
2017
205
17
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
European Urology
2021
198
18
First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localised Prostate Cancer
European Urology
2008
197
19
Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?
European Urology
2008
179
20
Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
European Urology
2011
176
21
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
European Urology
2014
156
22
Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
European Urology
2008
148
23
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes
Cancer Immunology Research
2019
148
24
ICUD-EAU International Consultation on Bladder Cancer 2012: Non–Muscle-Invasive Urothelial Carcinoma of the Bladder
European Urology
2013
137
25
Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool
European Urology
2014
134
26
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
European Urology
2020
132
27
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
Oncogene
2007
127
28
Sleep Apnea is an Independent Correlate of Erectile and Sexual Dysfunction
Journal of Sexual Medicine
2009
120
29
Eight Years' Experience With High-Intensity Focused Ultrasonography for Treatment of Localized Prostate Cancer
Urology
2008
114
30
Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”
European Urology Focus
2019
112
31
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review
European Urology Focus
2019
103
32
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
Annals of Oncology
2019
96
33
Topographical Anatomy of Periprostatic and Capsular Nerves: Quantification and Computerised Planimetry
European Urology
2008
95
34
Photodynamic Diagnostics and Noninvasive Bladder Cancer: Is It Cost-Effective in Long-Term Application? A Germany-Based Cost Analysis
European Urology
2007
90
35
Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer
World Journal of Urology
2006
86
36
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer
BJU International
2011
86
37
FGFR3 Mutations and a Normal CK20 Staining Pattern Define Low-Grade Noninvasive Urothelial Bladder Tumours
European Urology
2007
84
38
Chromosome 9 deletions are more frequent thanFGFR3 mutations in flat urothelial hyperplasias of the bladder
International Journal of Cancer
2006
83
39
Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis
Urology
2014
82
40
High Frequency of FGFR3 Mutations in Adenoid Seborrheic Keratoses
Journal of Investigative Dermatology
2006
79
41
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer
European Urology
2014
79
42
Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-–small cell lung cancer
Human Pathology
2008
76
43
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab
European Journal of Cancer
2019
75
44
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder
BJU International
2012
74
45
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer
European Urology Focus
2019
74
46
Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration
World Journal of Urology
2008
73
47
Evolution and Outcomes of 3 MHz High Intensity Focused Ultrasound Therapy for Localized Prostate Cancer During 15 Years
Journal of Urology
2013
69
48
A Comparison of Outcomes for Interfascial and Intrafascial Nerve-sparing Radical Prostatectomy
Urology
2010
68
49
PSA Nadir Is a Significant Predictor of Treatment Failure after High-Intensity Focussed Ultrasound (HIFU) Treatment of Localised Prostate Cancer
European Urology
2008
67
50
Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the Bladder
Gender Medicine
2012
65
site/software ©
exaly
; All materials licenced under
CC by-SA
.